Cubist Pharmaceuticals (CBST)

Add to Watchlists Create an Alert
55.49 -0.54  -0.96%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Cubist Pharmaceuticals Revenue Quarterly YoY Growth:

8.61% for March 31, 2013
View Full Chart

Cubist Pharmaceuticals Revenue Quarterly YoY Growth Chart

    Cubist Pharmaceuticals Historical Revenue Quarterly YoY Growth Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 8.61%
    Dec. 31, 2012 15.51%
    Sept. 30, 2012 18.09%
    June 30, 2012 30.38%
    March 31, 2012 30.25%
    Dec. 31, 2011 31.58%
    Sept. 30, 2011 24.47%
    June 30, 2011 4.92%
    March 31, 2011 12.82%
    Dec. 31, 2010 -2.95%
    Sept. 30, 2010 12.90%
    June 30, 2010 28.87%
    March 31, 2010 18.95%
    Dec. 31, 2009 27.12%
    Sept. 30, 2009 27.66%
    June 30, 2009 28.51%
    March 31, 2009 37.18%
    Dec. 31, 2008 53.25%
    Sept. 30, 2008 40.90%
    June 30, 2008 45.87%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Revenue Growth

    Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.

    If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
    Learn More

    Get data for

    CBST Revenue Quarterly YoY Growth Benchmarks

    Companies
    Optimer Pharmaceuticals -69.80%
    Celgene Corporation 15.02%
    Athersys -10.76%

    CBST Revenue Quarterly YoY Growth Rankings

    Overall 76th percentile
    1870 of 8011
    Sector 66th percentile
    230 of 687 in Healthcare
    Industry 73rd percentile
    66 of 248 in Biotechnology

    CBST Revenue Quarterly YoY Growth Range, Past 5 Years

    Minimum -2.95% Dec 2010
    Maximum 53.25% Dec 2008
    Average 24.75%